RaphHamers

Associate Professor Infectious Diseases, Oxford University Clinical Research Unit Indonesia @TropMedOxford @OUCRU_ID @OUCRU_Programme @Medicine_UI Views my own

[Tropical Medicine Oxford @TropMedOxford]

#ResearchHighlight from Gilbert Lazarus & @raphhamers OUCRU

#AMR in bacterial pathogens causing community-acquired and hospital-acquired lower respiratory tract infections (2010–24): systematic review and meta-analysis

👉 https://t.co/u9xOSB5B1B
Paper 👉 https://t.co/dXh4zd8kDl

[MORU @MORUBKK]

Finally! 4 years after scientific fraud & politicised science derailed it, #COPCOV, the world’s largest COVID-19 chemoprevention study, published results today in @PLOSMedicine: Hydroxychloroquine (HCQ) does have a moderate benefit in preventing #COVID-19
https://t.co/NJS3HtiUZY

[Dr Leigh Jones @drleighannjones]

Huge congratulations to Dr Robert Sinto of @MORUBKK and @OUCRUID for passing his @TropMedOxford DPhil viva with minor corrections! His project focussed on antimicrobial-resistant infections, and diagnostic and antimicrobial stewardship practices in inpatients in Indonesia🎓

[Tropical Medicine Oxford @TropMedOxford]

#MeetOurResearchers video interview with @raphhamers @OUCRUID @OUCRU_Programme

#InfectiousDiseases research in Indonesia

OUCRU Indonesia address prevention, diagnosis and management, focusing on TB, HIV, COVID19 and AMR

https://t.co/xD3JPu0Em1

[RaphHamers @raphhamers]

Early/Mid-Career scientists from the Southeast Asia region: apply for this great opportunity!

MODRA can support your research career by building skills, help prepare funding applications, and fostering a vibrant community of researchers

[OUCRU @OUCRU_Programme]

NEWS 📢 The MORU-OUCRU Discovery Research Academy #MODRA is open for registration. This 18-month programme empowers early & mid-career researchers in #SouthAsia to secure #ResearchFunding

📌 Apply by May 31st https://t.co/xCAEn1Bif7
📌 https://t.co/T99zA6XYmR

[RaphHamers @raphhamers]

@TropMedOxford @CGHRinfo @MORUBKK @OUCRU_Programme @KEMRI_Wellcome Congrats Susie, good luck with the new job!

[The Lancet Reg Health-Southeast Asia @LancetRH_SEAsia]

High #antimicrobialresistance (AMR) is prevalent in #Indonesia, especially in gram-negative #bacteria. Insufficient data calls for urgent implementation of national AMR surveillance to inform context-specific interventions & manage severe infections

https://t.co/BwNIq7dKff

[Tropical Medicine Oxford @TropMedOxford]

Congratulations Marlous Grijsen @GrijsenMarlous @OUCRUID @OUCRU_Programme

Marlous was awarded a GLODERM x CeraVe Access Grants, for her project: Tackling the under-recognised burden of neglected #SkinDisease on the island of Sumba, Eastern Indonesia

https://t.co/Xtr6HAJuzc

[OUCRU @OUCRU_Programme]

Researchers from 🇻🇳 Vietnam, 🇿🇦 South Africa, 🇳🇵 Nepal, 🇬🇭 Ghana, 🇮🇳 India, and 🇮🇩 Indonesia sharing diverse insights on ongoing non-COVID projects.

Promoting knowledge exchange across borders fuels healthcare innovation!

#RECOVERYTrial #RECOVERYMeeting2024 @OUCRUID

[World Health Organization (WHO) @WHO]

Thanks to vaccines, many fatal diseases are preventable:

cervical cancer,
cholera,
diphtheria,
Ebola,
hep B,
influenza,
Japanese encephalitis,
malaria,
measles,
meningitis,
mumps,
pertussis,
pneumonia,
polio,
rabies,
rotavirus,
rubella,
tetanus,
typhoid,
varicella,
yellow fever

Don’t delay.
Vaccinate today. #VaccinesWork!

[RaphHamers @raphhamers]

Our latest paper identified host #microRNAs that were associated with poor CD4+ T-cell recovery during suppressive ART for #hiv, to improve our understanding of the mechanisms of residual immune dysregulation @AIDS_Journal @aighd @amsterdamumc https://t.co/HePEJUwEyG

[RaphHamers @raphhamers]

Our latest paper describes a large patient cohort highlighting major challenges in the diagnosis and management of brain infections in #Indonesia #tuberculosis #hiv #cnsinfection
@OUCRUID @Medicine_UI @Darma_Imran @TropMedOxford

[Tropical Medicine Oxford @TropMedOxford]

Research Highlight from Raph Hamers @raphhamers @OUCRU_Programme @OUCRUID
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron #SARSCoV2 infection in Indonesia (2020–2023): a multicentre cohort study
https://t.co/jmlRXQpbC4
https://t.co/hXyNrjhmsa

[The Lancet Reg Health-Southeast Asia @LancetRH_SEAsia]

Infections by #SARSCoV2 #omicron variant resulted in less severe and fatal outcomes than delta in hospitalised patients in #Indonesia. However, older, and unvaccinated individuals remained at greater risk of adverse outcomes

Read the research article
👉https://t.co/KIujqtdKii

[RaphHamers @raphhamers]

Our latest paper documenting #SARSCoV2 pre-delta, delta and omicron in Indonesian hospitals ('20-'23). The elderly and unvaccinated remain at risk of adverse outcomes of #omicron infection @LancetRH_SEAsia @OUCRUID @TropMedOxford @Medicine_UI https://t.co/iVyH9Vfbb6

[RaphHamers @raphhamers]

Today we had the honour to host the @wellcometrust CEO Paul Schreier (interim) and @jarottingen (incoming) @OUCRUID to meet our team and share the research we do with our local partners to tackle infectious diseases in #Indonesia @TropMedOxford @OUCRU_Programme @Medicine_UI

[RaphHamers @raphhamers]

@Susannajd @vibrant_uk @pitchstudy @PKlenermanLab @AlexRichter3 @kungfudoctor @SMHopkins well done Yanie! enjoy the conference !

[RaphHamers @raphhamers]

Exciting DPhil opportunities at @OUCRUID in Indonesia #digitalhealth #diagnostics #acutehiv #vaccines #motherchildcare

[Oxford University Clinical Research Unit Indonesia @OUCRUID]

🎓 [Dphil Opportunities] Join captivating research themes at OUCRU Indonesia!
👉 Details: https://t.co/wRozmG8DRr

Apply by Dec 1st, 2023!

[Oxford University Clinical Research Unit Indonesia @OUCRUID]

🎓 [Dphil Opportunities] Join captivating research themes at OUCRU Indonesia!
👉 Details: https://t.co/wRozmG8DRr

Apply by Dec 1st, 2023!

[RaphHamers @raphhamers]

@Rukie_deAlwis @Le_Van_Tan @OUCRU_Programme @NDMOxford Yes Rukie this opportunity is in my group at OUCRU Indonesia

[RaphHamers @raphhamers]

[PhD opportunity] Interested in social science research on #vaccine #hesitancy in #Indonesia?

Join our team in #Jakarta on the research “Access and acceptance of newly introduced vaccines in Indonesia” @OUCRU_ID @OUCRU_Programme @NDMOxford

https://t.co/q6HRc0rn5H